CN103599521A - Vitamin D complex granules - Google Patents

Vitamin D complex granules Download PDF

Info

Publication number
CN103599521A
CN103599521A CN201310554277.4A CN201310554277A CN103599521A CN 103599521 A CN103599521 A CN 103599521A CN 201310554277 A CN201310554277 A CN 201310554277A CN 103599521 A CN103599521 A CN 103599521A
Authority
CN
China
Prior art keywords
vitamin
osteoporosis
bone
fracture
complex granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310554277.4A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUZHOU RANXIN BIOLOGICAL TECHNOLOGY Co Ltd
Original Assignee
SUZHOU RANXIN BIOLOGICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU RANXIN BIOLOGICAL TECHNOLOGY Co Ltd filed Critical SUZHOU RANXIN BIOLOGICAL TECHNOLOGY Co Ltd
Priority to CN201310554277.4A priority Critical patent/CN103599521A/en
Publication of CN103599521A publication Critical patent/CN103599521A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses vitamin D complex granules which are mainly prepared from calcium lactate, casein phosphopeptide and vitamin D.

Description

A kind of compound vitamin D electuary
Technical field
The invention belongs to biomedicine field, be specifically related to a kind of compound vitamin D electuary.
Background technology
Osteoporosis is a kind of commonly encountered diseases and frequently-occurring disease, and it is seriously threatening middle-aged and elderly people, and especially postmenopausal women is healthy.The complication such as the fracture being caused by osteoporosis, have caused great misery to patient, return society and family and have brought heavy economy and living burden.According to reports, the probability that the osteoporotic women of generation occurred hip, spinal column, forearm or proximal humeral fracture in 10 years later in 50 years old is up to 45%; Be greater than 65 years old old man when unconscious falling, have 87% can cause osteoporotic fracture.China old people's absolute quantity accounts for No. 1 in the world, and along with the growth of growth in the living standard and population life, the aged sharply increases, and therefore, the diagnosis of osteoporosis and control thereof just seem very important.
Osteoporosis can be divided into three major types, and a class is primary osteoporosis, is a kind of physiological degeneration that must occur with advancing age.Equations of The Second Kind is secondary osteoporosis, and it is the osteoporosis of being brought out by some factors such as Other diseases or medicines.The 3rd class is idiopathic osteoporosis disease, is more common in teenager or the adult of 8~14 years old, mostly has family's heredity medical history, and women is more than male.The osteoporosis that gravid woman and women breast-feeding their children occur also can be listed idiopathic osteoporosis in, to cause people's attention.
The main clinical manifestation of osteoporosis and sign are: pain, height shortening, hunchback, fragility fractures and Respiratory Disturbances etc.
1) pain
Pain is the common sympton of osteoporosis, and its reason is mainly that bone resorption increases because bone conversion is high.In bone resorption process, bone trabecular destruction, disappearance, the destruction of subperiosteum cortical bone etc. all can cause general osteodynia, wherein common with lumbago and backache.Another causes that the major reason of pain is fracture.
2) height shortening, hunchback
In silent middle height, shortening or bow-backed, is one of important clinical sign occurring continue lumbago and backache after, and 5-20 centimetre of height shortening is not sometimes etc.
3) fragility fractures
In osteoporosis, skeleton fracture threshold reduces significantly, thereby just easily fractured by slight external force.
4) Respiratory Disturbances
Breast, compression fracture of lumbar vertebra due to serious osteoporosis, usually cause kyphosis, chest deformity, and thoracic cavity capacity obviously declines, and sometimes can cause the changes of function of a plurality of internal organs, and wherein the performance of respiratory system is particularly outstanding.
The final purpose of protect against osteoporosis is to reduce the generation of fracture.Adopt clinically and delay and reduce bone loss, strive for recapturing bone amount, increase bone strength and reach this object.The treatment measure of osteoporosis is divided into basic measure and two aspects of Drug therapy.In the measure of basis, bone health supplement are mainly calcium preparation and vitamin D; Drug therapy mainly comprises anti-bone resorption medicine, short bone formation medicine and other drug.
Summary of the invention
The object of the present invention is to provide a kind of compound vitamin D electuary.
For achieving the above object, the present invention adopts the component of following weight ratio: 20 parts of calcium lactate, 5 parts of phosphopeptide caseinates, 0.05 part of vitamin D.
The above-mentioned edible or pharmaceutic adjuvant that can add comprises: diluent, suspending agent, antioxidant, emulsifying agent, disintegrating agent, adhesive and antiseptic.
The specific embodiment
Embodiment 1: a kind of compound vitamin D electuary, its raw material and weight portion are: 20 parts of calcium lactate, 5 parts of phosphopeptide caseinates, 0.05 part of vitamin D.

Claims (1)

1. a compound vitamin D electuary, is characterized in that, comprises the component of following weight ratio: 20 parts of calcium lactate, 5 parts of phosphopeptide caseinates, 0.05 part of vitamin D.
CN201310554277.4A 2013-11-08 2013-11-08 Vitamin D complex granules Pending CN103599521A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310554277.4A CN103599521A (en) 2013-11-08 2013-11-08 Vitamin D complex granules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310554277.4A CN103599521A (en) 2013-11-08 2013-11-08 Vitamin D complex granules

Publications (1)

Publication Number Publication Date
CN103599521A true CN103599521A (en) 2014-02-26

Family

ID=50117827

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310554277.4A Pending CN103599521A (en) 2013-11-08 2013-11-08 Vitamin D complex granules

Country Status (1)

Country Link
CN (1) CN103599521A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1381270A (en) * 2002-04-29 2002-11-27 徐佳立 Ca-supplementing instant composite polypeptide powder and its preparing process
CN102302116A (en) * 2011-06-10 2012-01-04 营养屋(成都)生物医药有限公司 Calcium supplementing and calcium locking health care food and preparation method thereof
CN103202483A (en) * 2012-01-11 2013-07-17 浙江康恩贝健康产品有限公司 Nutritional composition for calcium supplement
US8557296B2 (en) * 2009-09-24 2013-10-15 Rajan V. Vembu Compositions and methods for the prevention and treatment of metabolic diseases

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1381270A (en) * 2002-04-29 2002-11-27 徐佳立 Ca-supplementing instant composite polypeptide powder and its preparing process
US8557296B2 (en) * 2009-09-24 2013-10-15 Rajan V. Vembu Compositions and methods for the prevention and treatment of metabolic diseases
CN102302116A (en) * 2011-06-10 2012-01-04 营养屋(成都)生物医药有限公司 Calcium supplementing and calcium locking health care food and preparation method thereof
CN103202483A (en) * 2012-01-11 2013-07-17 浙江康恩贝健康产品有限公司 Nutritional composition for calcium supplement

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FELIX BRONNER ETAL: "Nutritional Aspects of Calcium Absorption", 《RECENT ADVANCES IN NUTRITIONAL SCIENCE》, 17 January 2011 (2011-01-17), pages 9 - 12 *
无: "宝育堂多维乳酸钙冲剂", 《YUER.PCBABY.COM.CN/YOUER/YINSHI/0807/299834.HTML》, 31 July 2008 (2008-07-31) *

Similar Documents

Publication Publication Date Title
CN103584106A (en) Composition capable of improving bone mineral density
CN103599186A (en) Compound lotus root starch preparation
CN103610755A (en) Granules for treating osteoporosis
CN104587470B (en) Pharmaceutical composition for promoting bone healing after osteoportic fracture operations and application of pharmaceutical composition
CN103565827A (en) Resveratrol-containing tablets
Chen et al. Intrathoracic dislocation of the humeral head accompanied by polytrauma: How to treat it
CN103599521A (en) Vitamin D complex granules
CN103599525A (en) Chelated calcium electuary
CN103611152A (en) Compound vitamin D electuary
CN103565830A (en) Composite calcium preparation
CN103599524A (en) Compound walnut powder solid preparation
CN103599096A (en) Resveratrol tablet
CN103610740A (en) Calcium chelate
ES2543557T3 (en) Effects of the association of vitamin K2 and vitamin D3 in the consolidation of a bone fracture
CN103566355A (en) Composite lotus root starch preparation
CN103599177A (en) Composition for enhancing bone density
CN103599168A (en) Composition for enhancing bone density
CN103599174A (en) Composition for improving bone mineral density
CN103585457B (en) A kind of medicament for the treatment of fracture
CN103565930A (en) Granule for increasing bone density
CN103585264A (en) Preparation capable of increasing bone mineral density
CN103599176A (en) Composition for enhancing bone density
CN103599175A (en) Granules for increasing bone density
CN103623048A (en) Preparation containing pueraria isoflavones
CN103735613A (en) Preparation for increasing bone mineral density

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140226